Bank of New York Mellon’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.43M | Buy |
200,634
+13,387
| +7% | +$629K | ﹤0.01% | 1931 |
|
2025
Q1 | $8.26M | Sell |
187,247
-8,695
| -4% | -$384K | ﹤0.01% | 1947 |
|
2024
Q4 | $7.08M | Sell |
195,942
-30,986
| -14% | -$1.12M | ﹤0.01% | 2102 |
|
2024
Q3 | $7.27M | Sell |
226,928
-72,033
| -24% | -$2.31M | ﹤0.01% | 2092 |
|
2024
Q2 | $11.3M | Buy |
298,961
+66,161
| +28% | +$2.49M | ﹤0.01% | 1898 |
|
2024
Q1 | $11.5M | Sell |
232,800
-8,322
| -3% | -$410K | ﹤0.01% | 1896 |
|
2023
Q4 | $8.8M | Buy |
241,122
+23,497
| +11% | +$858K | ﹤0.01% | 2046 |
|
2023
Q3 | $5.03M | Sell |
217,625
-2,678
| -1% | -$61.9K | ﹤0.01% | 2310 |
|
2023
Q2 | $5.78M | Buy |
220,303
+93,143
| +73% | +$2.44M | ﹤0.01% | 2240 |
|
2023
Q1 | $3.27M | Buy |
127,160
+1,242
| +1% | +$32K | ﹤0.01% | 2525 |
|
2022
Q4 | $3.28M | Sell |
125,918
-24,536
| -16% | -$638K | ﹤0.01% | 2576 |
|
2022
Q3 | $4.29M | Buy |
150,454
+22,733
| +18% | +$649K | ﹤0.01% | 2368 |
|
2022
Q2 | $3.15M | Buy |
127,721
+11,198
| +10% | +$276K | ﹤0.01% | 2579 |
|
2022
Q1 | $6.58M | Sell |
116,523
-602
| -0.5% | -$34K | ﹤0.01% | 2281 |
|
2021
Q4 | $7.26M | Buy |
117,125
+769
| +0.7% | +$47.7K | ﹤0.01% | 2268 |
|
2021
Q3 | $7.38M | Buy |
116,356
+7,360
| +7% | +$467K | ﹤0.01% | 2288 |
|
2021
Q2 | $8.98M | Buy |
108,996
+19,006
| +21% | +$1.57M | ﹤0.01% | 2203 |
|
2021
Q1 | $6.62M | Sell |
89,990
-2,102
| -2% | -$155K | ﹤0.01% | 2313 |
|
2020
Q4 | $6.68M | Buy |
92,092
+16,582
| +22% | +$1.2M | ﹤0.01% | 2217 |
|
2020
Q3 | $3.6M | Buy |
75,510
+530
| +0.7% | +$25.3K | ﹤0.01% | 2386 |
|
2020
Q2 | $3.15M | Buy |
74,980
+35,720
| +91% | +$1.5M | ﹤0.01% | 2441 |
|
2020
Q1 | $1.06M | Buy |
39,260
+13,179
| +51% | +$356K | ﹤0.01% | 2936 |
|
2019
Q4 | $1M | Buy |
+26,081
| New | +$1M | ﹤0.01% | 3243 |
|